Thermotherapy in Addition to SOC Palliative Radiotherapy

This study aims to investigate the efficacy and safety profile of superficial hyperthermia (wIRA) in addition to standard of care (SOC) palliative radiotherapy in patients with inoperable/incurable locally advanced or recurrent/metastatic HNSCC or cutaneous SCC superficial tumours not suitable for radical treatment. The investigators will assess the best objective response rate (ORR) of patients with Inoperable/incurable or recurrent/metastatic HNSCC or cSCC with superficial lesion(s) treated with the combination of superficial hyperthermia (wIRA) and palliative radiotherapy.

Trial Details

NCT ID
NCT06659146
Phase
NA
Sponsor
King's College London
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • Superficial hyperthermia
Locations (sample)
  • London, United Kingdom|51.50853,-0.12574
  • London, United Kingdom|51.50853,-0.12574

Key Eligibility Criteria

  • Patient with histologically confirmed incurable or inoperable cancers with disease \[at least one superficial lesion(s) or lymph node(s)\] suitable…
  • Patient undergoing standard of care palliative radiotherapy (suitable with the pre-specified dose and fractionation in the protocol
  • Aged ≥18 years old
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →